TY - BOOK ID - 103930641 TI - Pharmaceuticals for targeting coronaviruses AU - Scotti, Luciana AU - Scotti, Marcus T PY - 2022 SN - 9815051326 981505130X 9815051318 9789815051308 PB - Singapore DB - UniCat KW - COVID-19 (Disease) KW - Drugs. KW - Medicaments KW - Medications KW - Medicine (Drugs) KW - Medicines (Drugs) KW - Pharmaceuticals KW - Prescription drugs KW - Bioactive compounds KW - Medical supplies KW - Pharmacopoeias KW - Chemotherapy KW - Materia medica KW - Pharmacology KW - Pharmacy KW - 2019-nCoV disease KW - 2019 novel coronavirus disease KW - Coronavirus disease-19 KW - Coronavirus disease 2019 KW - COVID-19 virus disease KW - COVID19 (Disease) KW - Novel coronavirus disease, 2019 KW - SARS coronavirus 2 disease KW - SARS-CoV-2 disease KW - Coronavirus infections KW - Respiratory infections UR - https://www.unicat.be/uniCat?func=search&query=sysid:103930641 AB - This reference summarizes information about pharmaceuticals that can target infectious strains of coronaviruses to neutralize infections. Chapters focus on SARS-CoV-2, drug discovery methods and natural methods to combat the virus, which is a causative agent of COVID-19. Specifically, the book presents 5 chapters written by expert scholar on the following topics: Structure-Based Drug Discovery Approaches Applied to SARS-CoV-2 (the causative agent COVID- 19)Potential Antiviral Medicinal Plants against Novel SARS-CoV-2Infections Caused by SARS Coronaviruses: Main Characteristics, Targets And Inhibitors Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID- 19Peptidomimetic and Peptide-Derived Agents Against 3CLpro from Coronaviruses The book contents present both conventional drug design and traditional approaches to discovering relevant drugs in an easy-to-read approach, which is supplemented by bibliographic references. It is intended as a reference for students (pharmacology, pharmacy) and researchers (virology) who are seeking information about antiviral drugs that can be used against coronaviruses. ER -